Arcadia Biosciences Files 8-K on Financials
Ticker: RKDA · Form: 8-K · Filed: Mar 20, 2025 · CIK: 1469443
| Field | Detail |
|---|---|
| Company | Arcadia Biosciences, Inc. (RKDA) |
| Form Type | 8-K |
| Filed Date | Mar 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Arcadia Biosciences dropped an 8-K on March 20th detailing their financial results. Check it out.
AI Summary
Arcadia Biosciences, Inc. filed an 8-K on March 20, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits. The company's principal executive offices are located in Dallas, Texas.
Why It Matters
This 8-K filing provides investors with an update on Arcadia Biosciences' financial performance and condition, which is crucial for assessing the company's health and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any immediate negative news or significant changes.
Key Players & Entities
- Arcadia Biosciences, Inc. (company) — Registrant
- March 20, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Dallas, Texas (location) — Address of Principal Executive Offices
FAQ
What specific financial information is being reported in this 8-K?
The 8-K filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K filed?
The filing was made on March 20, 2025.
What is the primary business of Arcadia Biosciences, Inc. as indicated by the SIC code?
The Standard Industrial Classification (SIC) code provided is 1311, which corresponds to 'CRUDE PETROLEUM & NATURAL GAS'.
Where are Arcadia Biosciences, Inc.'s principal executive offices located?
The principal executive offices are located at 5950 Sherry Lane Suite 215, Dallas, Texas, 75225.
What is the Commission File Number for Arcadia Biosciences, Inc.?
The Commission File Number is 001-37383.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 20, 2025 regarding Arcadia Biosciences, Inc. (RKDA).